MTOR and diffuse large B-cell lymphoma: Less frequent, mutations in the PIK3CA gene or amplifications of PIK3CA are observed in 1.3–12% of DLBCL (93–96) and they are mutually exclusive with PTEN loss, which further define another PI3K/Akt/mTOR-regulated DLBCL subset (94).